MedTrace Logo

Global Sinus Surgery Registry

NCT02347943 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2024-07-12

Study results available
· View outcomes & findings →

Summary

This study evaluates long-term safety and effectiveness of primary sinus surgery in a real-world population of adults with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS). This post-market study will evaluate sinus surgery performed using commercially available sinus instrumentation (e.g. sinus balloon catheters, powered microdebriders, manual instruments).

Conditions

  • Chronic Rhinosinusitis
  • Recurrent Acute Rhinosinusitis

Sponsors & Collaborators

  • Acclarent

    collaborator INDUSTRY

  • Integra LifeSciences Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-11-01
Completion
2015-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02347943 on ClinicalTrials.gov